Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With Hypogonadism
The study is designed to answer the following questions:
- Is hypogonadism a cause for the metabolic syndrome ?
- What is the effect of testosterone replacement on the metabolic parameters ?
|Study Design:||Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Screening
|Official Title:||Phase 4 Study of About the Effect of Testosterone Treatment on the Components of Metabolic Syndrome|
|Study Start Date:||August 2009|
|Study Completion Date:||January 2010|
|Primary Completion Date:||January 2010 (Final data collection date for primary outcome measure)|
|Experimental: Testosteron, secondary hypogonadism||
Testosteron 250mg injection per 3-4 weeks for 6 months
Other Name: Sustanon 250mg
This is a retrospective design, which is performed by investigating the registrations of patients with hypogonadotrophic hypogonadism between the years 2002-2009.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01160341
|Gulhane School of Medicine|
|Ankara, Turkey, 06018|